| Action | Amend regulation to require each family day home provider or other caregiver to be trained in epinephrine administration; notification requirements to parents required |
| Stage | Fast-Track |
| Comment Period | Ended on 12/17/2025 |
![]() |
The Problem:
Stock epinephrine auto-injectors (EpiPens) are expensive pharmaceutical products with limited shelf life. Unlike one-time purchases, this represents an ongoing operational cost that providers must budget for indefinitely.
Specific Cost Factors:
• EpiPen Junior (for children 33-66 lbs): Approximately $300-650 for a 2-pack
• EpiPen Regular (for children over 66 lbs): Approximately $300-650 for a 2-pack
• Most facilities would need both sizes to cover different age groups
• EpiPens expire after 12-18 months and must be replaced
• Annual replacement costs even if never used
Additional Financial Considerations:
• Small family-based providers often operate with minimal profit margins
• Many providers are already struggling with rising costs (food, supplies, insurance)
• State reimbursement rates for subsidized care haven't kept pace with costs
• Passing costs to families makes child care less affordable in an already expensive market
• Some providers may be forced to close rather than absorb these costs
Impact on Families:
• Increased tuition rates across the board
• Reduced access to affordable child care
• Particular burden on working families already struggling with costs